PharmaliZr - a medicine serialisation solution

Context

Against a backdrop in which counterfeit medicines represent an annual loss of more than 1 billion euros in France and 10.5 billion in Europe, Eirwego is developing PharmaliZr, an innovative solution for verifying medicines by scanning datamatrix codes. From its creation in 2018 to today, the solution has never stopped evolving to meet market needs and regulatory requirements.

Issues identified

• A public health issue: the fight against counterfeit medicines
• Technical complexity: the need for a multi-device solution with no installation
• Regulatory constraints: mandatory certification by France MVO, the French medicines verification organisation
• Scalability: continuous adaptation to user needs and European standards

What was at stake in the transformation

The project was built around three strategic areas:

1. Maximum accessibility

   • A cross-platform web solution
   • On-Premise and SaaS versions
   • A REST API for third-party integrations

2. Technical excellence

   • A modern, scalable architecture
   • Optimal performance
   • Strengthened security

3. User experience

   • An intuitive interface
   • Adaptation to the contexts of use
   • Advanced alert management

Our approach

Our work was structured in two major phases:

1. Initial creation (2018)

• UX/UI design

  • Co-building with pharmacists
  • Mobile-first design
  • Optimised user journeys

• Technical architecture

  • A modern stack (React, Symfony)
  • A documented REST API
  • Continuous deployment

2. Major evolution (2022)

• UX improvements

  • A redesign of the user journeys
  • Advanced alert management
  • Dark/light mode support

• Technical optimisation

  • Improved performance
  • New integrations
  • Strengthened security

Key features

1. Medicine verification

• Intelligent scanning

  • Reading datamatrix codes
  • Real-time verification
  • Handling anomalies

• End-to-end traceability

  • A history of verifications
  • Batch tracking
  • Detailed reporting

2. Alert management

• An intelligent system
  • Automatic detection
  • Prioritising alerts
  • Recommended actions

3. Adaptive interfaces

• Multi-device
  • A responsive desktop version
  • A mobile application
  • A dedicated terminal (PDA)

Results

1. Institutional recognition

• France MVO certification obtained
• A pioneering position in the market
• A benchmark solution for the sector

2. User adoption

• Customer satisfaction
  • An intuitive interface that users praise
  • Optimised processes
  • Responsive support

3. Technical performance

• A scalable, robust solution
• Successful integration with the existing systems
• Simplified maintenance

Business impact

The PharmaliZr solution achieved the following:

• An active contribution to the fight against counterfeiting
• A leading position in the French market
• Growing adoption by professionals
• A solid base for European expansion

This evolution illustrates how a user-centred approach, combined with technical excellence, can create an innovative solution that answers a major public health issue.